Blueprint Medicines Corp (NASDAQ:BPMC)

100.98
Delayed Data
As of Jan 15
 -1.53 / -1.49%
Today’s Change
43.29
Today|||52-Week Range
125.61
-9.96%
Year-to-Date

Today’s Trading

Previous close102.51
Today’s open102.74
Day’s range100.65 - 102.74
Volume17,505
Average volume (3 months)502,903
Market cap$5.6B
Data as of 3:58pm ET, 01/15/2021

Growth & Valuation

Earnings growth (last year)-34.76%
Earnings growth (this year)+175.53%
Earnings growth (next 5 years)+34.00%
Revenue growth (last year)+49.39%
P/E ratio17.2
Price/Sales57.61
Price/Book10.69

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.24+0.23%
----
EIDXEidos Therapeutics I...-2.00-1.56%
HALOHalozyme Therapeutic...+0.39+0.83%
Data as of 4:00pm ET, 01/15/2021

Financials

Next reporting dateMarch 5, 2021
EPS forecast (this quarter)-$1.60
Annual revenue (last year)$66.5M
Annual profit (last year)-$347.7M
Net profit margin-522.75%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts